AS

Abhishek Shirish Nagpurkar

Active Director Director DIN 08375618
DIN 08375618 First appointment Feb 2019 Primary industry Trading
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Feb 2019
Shareholding value •••• Premium profile

About Abhishek Shirish Nagpurkar

Data last updated:

Abhishek Shirish Nagpurkar is a Director at Empros Pharmaceuticals Private Limited (since 2019). The company operates in Trading. Empros Pharmaceuticals Private Limited reported revenue of ₹26.7 Lakh (FY 2025).

DIN 08375618
Primary Designation Director
Industry Trading
First Appointment 15 Feb 2019
Oldest Company Age 8 yrs
Largest company Empros Pharmaceuticals Private Limited · ₹26.7 Lakh (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director15 Feb 20192018₹26.7 Lakh (FY 2025)Active

Board colleagues of Abhishek Shirish Nagpurkar

Directorship timeline

Open interactive timeline →
Empros Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Abhishek Shirish Nagpurkar

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Abhishek Shirish Nagpurkar

Abhishek Shirish Nagpurkar currently holds 1 directorship: Empros Pharmaceuticals Private Limited (Director, since 15 Feb 2019, revenue ₹26.7 Lakh (FY 2025)).

Abhishek Shirish Nagpurkar was first appointed on 15 Feb 2019 as Director at Empros Pharmaceuticals Private Limited.

The current boards of Abhishek Shirish Nagpurkar's companies include Kishan Vitthalsingh Dewade (Empros Pharmaceuticals Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available